The article Enveric Biosciences Reports Q4 and Year-End 2022 Results was originally published on Microdose. Enveric Biosciences Reports Fourth Quarter...
KWC recently closed its clinics due to financial problems. The post Startup Hormonal Wellness Platform to Buy Ketamine Wellness Centers appeared first...
Conflating drug use with addiction causes a wide variety of issues. Years of fear-mongering and moralizing regarding drug use, particularly in the US but...
The company made $364,500 in licensing revenues. The post Psychedelic Research Firm Filament Health Grows Pipeline in 2022 appeared first on Green Market...
Filament Health Corp. (OTCQB: FLHLF / NEO: FH / FSE: 7QS), a clinical-stage natural psychedelic drug development company, released its fourth quarter...
Psychedelic Facilitators vs. Psychedelic Therapists Psychedelic therapists and psychedelic facilitators are not the same, though they both have important...
The article Chrisitian Angermayer Shows Faith in Atai, Buys Another 1.2 M Shares was originally published on Microdose. On March 29th, Christian Angermayer,...
The company's debts totaled C$136.5 million by the end of 2022. The post Mydecine Cuts Down on Annual Cash Burn Despite Mounting Debt appeared first on...
The article News You Might Have Missed: April 3rd, 2023 was originally published on Microdose. Welcome to the News You Might Have Missed, a weekly roundup...
The munKNEE Psychedelic Drug Stocks Index was DOWN 3.4% in March but is still UP 1.2% YTD and the average price targets of the above stocks represent...